AAAAAA

   
Results: 1-25 | 26-44 |
Results: 26-44/44
ANTITUMOR EFFICACY AND BIODISTRIBUTION OF INTRAVENOUS POLYMERIC MICELLAR PACLITAXEL
Authors: ZHANG XC BURT HM MANGOLD G DEXTER D VONHOFF D MAYER L HUNTER WL
Citation: Xc. Zhang et al., ANTITUMOR EFFICACY AND BIODISTRIBUTION OF INTRAVENOUS POLYMERIC MICELLAR PACLITAXEL, Anti-cancer drugs, 8(7), 1997, pp. 696-701
A PHASE-I CLINICAL-TRIAL WITH ONYX-015 (A SELECTIVELY REPLICATING ADENOVIRUS) ADMINISTERED BY INTRATUMORAL INJECTION IN PATIENTS WITH RECURRENT HEAD AND NECK-CARCINOMA
Authors: KIRN D GANLEY I NEMUNAITIS J OTTO R SOUTAR D KUHN J HEISE C PROPST M MAACK C ECKHARDT G KAYE S VONHOFF D
Citation: D. Kirn et al., A PHASE-I CLINICAL-TRIAL WITH ONYX-015 (A SELECTIVELY REPLICATING ADENOVIRUS) ADMINISTERED BY INTRATUMORAL INJECTION IN PATIENTS WITH RECURRENT HEAD AND NECK-CARCINOMA, Cancer gene therapy, 4(6), 1997, pp. 5-5
PRECLINICAL STUDIES WITH ONYX-015 (A REPLICATION COMPETENT E1B-DELETED ADENOVIRUS) IN COMBINATION WITH CHEMOTHERAPY
Authors: HEISE C WILLIAMS A PROPST M SAMPSONJOHANNES A WEBER S DAVIDSON K IZBICKA E VONHOFF D KIRN D
Citation: C. Heise et al., PRECLINICAL STUDIES WITH ONYX-015 (A REPLICATION COMPETENT E1B-DELETED ADENOVIRUS) IN COMBINATION WITH CHEMOTHERAPY, Cancer gene therapy, 4(6), 1997, pp. 6-6
MITOGUAZONE THERAPY IN PATIENTS WITH REFRACTORY OR RELAPSED AIDS-RELATED LYMPHOMA - RESULTS FROM A MULTICENTER PHASE-II TRIAL
Authors: LEVINE AM TULPULE A TESSMAN D KAPLAN L GILES F LUSKEY BD SCADDEN DT NORTHFELT DW SILVERBERG I WERNZ J ESPINA B VONHOFF D
Citation: Am. Levine et al., MITOGUAZONE THERAPY IN PATIENTS WITH REFRACTORY OR RELAPSED AIDS-RELATED LYMPHOMA - RESULTS FROM A MULTICENTER PHASE-II TRIAL, Journal of clinical oncology, 15(3), 1997, pp. 1094-1103
AN INVESTIGATION OF THE ANTITUMOR-ACTIVITY AND BIODISTRIBUTION OF POLYMERIC MICELLAR PACLITAXEL
Authors: ZHANG XC BURT HM VONHOFF D DEXTER D MANGOLD G DEGEN D OKTABA AM HUNTER WL
Citation: Xc. Zhang et al., AN INVESTIGATION OF THE ANTITUMOR-ACTIVITY AND BIODISTRIBUTION OF POLYMERIC MICELLAR PACLITAXEL, Cancer chemotherapy and pharmacology, 40(1), 1997, pp. 81-86
AN IN-VITRO ASSESSMENT OF THE ANTINEOPLASTIC POTENTIAL OF 2H-1,3-OXAZINE-2,6(3H)-DIONE (3-OXAURACIL), A NOVEL PYRIMIDINE
Authors: SEAL L VONHOFF D LAWRENCE R IZBICKA E JAMISON RM
Citation: L. Seal et al., AN IN-VITRO ASSESSMENT OF THE ANTINEOPLASTIC POTENTIAL OF 2H-1,3-OXAZINE-2,6(3H)-DIONE (3-OXAURACIL), A NOVEL PYRIMIDINE, Investigational new drugs, 15(4), 1997, pp. 289-293
ATTEMPTED ENCOUNTER - PSYCHOANALYTIC AND TEXT-ANALYTIC APPROACHES TO JELINEK,ELFRIEDE LUST
Authors: VONHOFF D LEUZINGERBOHLEBER M
Citation: D. Vonhoff et M. Leuzingerbohleber, ATTEMPTED ENCOUNTER - PSYCHOANALYTIC AND TEXT-ANALYTIC APPROACHES TO JELINEK,ELFRIEDE LUST, Psyche, 51(8), 1997, pp. 763-800
INHIBITION OF TELOMERES AND TELOMERASE - SEEKING FOR NEW ANTICANCER DRUGS
Authors: RAYMOND E FAIVRE S DIERAS V VONHOFF D
Citation: E. Raymond et al., INHIBITION OF TELOMERES AND TELOMERASE - SEEKING FOR NEW ANTICANCER DRUGS, Bulletin du cancer, 84(12), 1997, pp. 1123-1133
FUTURE-DIRECTIONS FOR CLINICAL RESEARCH WITH CPT-11 (IRINOTECAN)
Authors: VONHOFF D
Citation: D. Vonhoff, FUTURE-DIRECTIONS FOR CLINICAL RESEARCH WITH CPT-11 (IRINOTECAN), European journal of cancer, 32A, 1996, pp. 9-12
SINGLE-DOSE THERAPY WITH RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPY
Authors: VADHANRAJ S BURRIS H BENJAMIN RS PATEL S JOHNSTON T HELLMANN S COHEN R WATANABE B VONHOFF D
Citation: S. Vadhanraj et al., SINGLE-DOSE THERAPY WITH RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN PATIENTS RECEIVING CYTOTOXIC CHEMOTHERAPY, Journal of clinical oncology, 14(5), 1996, pp. 2010-2010
SHORT-TERM IMPACT OF MITOGUAZONE (MGBG) CHEMOTHERAPY ON HIV VIRAL LOAD IN PATIENTS WITH RELAPSED REFRACTORY AIDS-LYMPHOMA/
Authors: LEVINE AM TULPULE A ROCHAT J ESPINA B MCPHEE R TESSMAN D VONHOFF D
Citation: Am. Levine et al., SHORT-TERM IMPACT OF MITOGUAZONE (MGBG) CHEMOTHERAPY ON HIV VIRAL LOAD IN PATIENTS WITH RELAPSED REFRACTORY AIDS-LYMPHOMA/, Blood, 88(10), 1996, pp. 2001-2001
DNA-SEQUENCE AMPLIFICATION IN HUMAN PROSTATE-CANCER IDENTIFIED BY CHROMOSOME MICRODISSECTION - POTENTIAL PROGNOSTIC IMPLICATIONS
Authors: VANDENBERG C GUAN XY VONHOFF D JENKINS R BITTNER M GRIFFIN C KALLIONIEMI O VISAKORPI T MCGILL J HERATH J EPSTEIN J SAROSDY M MELTZER P TRENT J
Citation: C. Vandenberg et al., DNA-SEQUENCE AMPLIFICATION IN HUMAN PROSTATE-CANCER IDENTIFIED BY CHROMOSOME MICRODISSECTION - POTENTIAL PROGNOSTIC IMPLICATIONS, Clinical cancer research, 1(1), 1995, pp. 11-18
A PHASE-I AND BIOAVAILABILITY STUDY OF ORAL TOPOTECAN
Authors: ECKARDT J BURRIS H RIZZO J FIELDS S RODRIGUEZ G DELACRUZ P HODGES S VONHOFF D KUHN J
Citation: J. Eckardt et al., A PHASE-I AND BIOAVAILABILITY STUDY OF ORAL TOPOTECAN, European journal of cancer, 31A, 1995, pp. 927-927
ABERRANT SUBCELLULAR-LOCALIZATION OF BRCA1 IN BREAST-CANCER
Authors: CHEN YM CHEN CF RILEY DJ ALLRED DC CHEN PL VONHOFF D OSBORNE CK LEE WH
Citation: Ym. Chen et al., ABERRANT SUBCELLULAR-LOCALIZATION OF BRCA1 IN BREAST-CANCER, Science, 270(5237), 1995, pp. 789-791
2 SEQUENTIAL PROSPECTIVE, MULTIINSTITUTIONAL PHASE-II CLINICAL-TRIALSOF MITOGUAZONE (MGBG) IN REFRACTORY OR RELAPSED AIDS-RELATED LYMPHOMA
Authors: LEVINE AM GILES F KAPLAN L SPARANO J SCADDEN D LUSKEY B NORTHFELT D THOMMAS J ANDERSON LJJ ESPINA B TESSMAN D VONHOFF D
Citation: Am. Levine et al., 2 SEQUENTIAL PROSPECTIVE, MULTIINSTITUTIONAL PHASE-II CLINICAL-TRIALSOF MITOGUAZONE (MGBG) IN REFRACTORY OR RELAPSED AIDS-RELATED LYMPHOMA, Blood, 86(10), 1995, pp. 1512-1512
PHASE-I TRIAL OF PSC-833 AND DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, AND PREDNISONE (DVCP) IN PATIENTS WITH REFRACTORY NON-HODGKINS-LYMPHOMA
Authors: COBB P BURRIS H WEISS G FIELDS S CRAIG J QUICK D COOK G PEARCE T VONHOFF D
Citation: P. Cobb et al., PHASE-I TRIAL OF PSC-833 AND DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, AND PREDNISONE (DVCP) IN PATIENTS WITH REFRACTORY NON-HODGKINS-LYMPHOMA, Blood, 84(10), 1994, pp. 10000167-10000167
PYRIDOXINE THERAPY FOR PALMAR PLANTAR ERYTHRODYSESTHESIA ASSOCIATED WITH TAXOTERE
Authors: VUKELJA SJ BAKER WJ BURRIS HA KEELING JH VONHOFF D
Citation: Sj. Vukelja et al., PYRIDOXINE THERAPY FOR PALMAR PLANTAR ERYTHRODYSESTHESIA ASSOCIATED WITH TAXOTERE, Journal of the National Cancer Institute, 85(17), 1993, pp. 1432-1433
PHASE-I CLINICAL-TRIAL OF TAXOTERE ADMINISTERED AS EITHER A 2-HOUR OR6-HOUR INTRAVENOUS-INFUSION
Authors: BURRIS H IRVIN R KUHN J KALTER S SMITH L SHAFFER D FIELDS S WEISS G ECKARDT J RODRIGUEZ G RINALDI D WALL J COOK G SMITH S VREELAND F BAYSSAS M LEBAIL N VONHOFF D
Citation: H. Burris et al., PHASE-I CLINICAL-TRIAL OF TAXOTERE ADMINISTERED AS EITHER A 2-HOUR OR6-HOUR INTRAVENOUS-INFUSION, Journal of clinical oncology, 11(5), 1993, pp. 950-958
AMPLIFICATION ON COMMENTS BY BERRY
Authors: HALBERG E CORNELISSEN G HAUS E FINE RL WALKER R VONHOFF D HALBERG F HALBERG J HALBERG F
Citation: E. Halberg et al., AMPLIFICATION ON COMMENTS BY BERRY, Chronobiologia, 20(3-4), 1993, pp. 214-218
Risultati: 1-25 | 26-44 |